Long-Term Tolerability and Safety Of Facilitated-Subcutaneous Infusion Of Human Immune Globulin G (IgG), 10%, and Recombinant Human Hyaluronidase (rHuPH20) (IGHy): A Phase 3 Extension Study In Patients With Primary Immunodeficiencies (PIs)

Isaac Reuven Melamed, Richard L. Wasserman, Mark Stein, Arye Rubinstein, Jennifer M. Puck, Sudhir Gupta, Werner Engl, Heinz Leibl, Leman Yel, Richard I. Schiff
  • Journal of Allergy and Clinical Immunology, February 2014, Elsevier
  • DOI: 10.1016/j.jaci.2013.12.645
The author haven't finished explaining this publicationThe author haven't finished explaining this publication

The following have contributed to this page: Dr Richard L Wasserman